PRELUDE CAPITAL MANAGEMENT, LLC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 55 filers reported holding SIO GENE THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q3 2021$74,000
-20.4%
34,0000.0%0.00%
-33.3%
Q2 2021$93,000
+4.5%
34,0000.0%0.00%
+50.0%
Q1 2021$89,000
-6.3%
34,0000.0%0.00%0.0%
Q4 2020$95,00034,0000.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,186,335$8,316,0000.89%
Opaleye Management Inc. 2,000,000$5,220,0000.77%
Prosight Management, LP 205,900$537,0000.44%
Rubric Capital Management LP 2,500,418$6,526,0000.38%
Sio Capital Management, LLC 460,248$1,201,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,326,0000.21%
KNOTT DAVID M 70,000$183,0000.08%
Insight Advisors, LLC/ PA 82,700$232,0000.07%
GSA CAPITAL PARTNERS LLP 146,968$384,0000.06%
Hudson Bay Capital Management LP 1,600,000$4,176,0000.05%
View complete list of SIO GENE THERAPIES INC shareholders